Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
about
Mild cognitive impairment: pathology and mechanisms.What can imaging tell us about cognitive impairment and dementia?Neuroimaging biomarkers of neurodegenerative diseases and dementiaPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesIdentification and Biochemical Properties of Two New Acetylcholinesterases in the Pond Wolf Spider (Pardosa pseudoannulata)Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's diseaseLooking for novel ways to treat the hallmarks of Alzheimer's disease.Positron emission tomography imaging in dementia.Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detectionManagement of behavioral problems in Alzheimer's disease.Alzheimer's disease and stem cell therapy.PET/CT in diagnosis of dementiaA review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia.The neurotrophins and their role in Alzheimer's disease.PET probes for imaging brain acetylcholinesterase.Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease.Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.Protective effects of Borago officinalis extract on amyloid β-peptide(25-35)-induced memory impairment in male rats: a behavioral study.Antioxidant potential of Amorphophallus paeoniifolius in relation to their phenolic content.Inhibitory role of cholinergic system mediated via alpha7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation.A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV.Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset.Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice.Highly sensitive and rapid detection of acetylcholine using an ITO plate modified with platinum-graphene nanoparticles.N-Benzoyl-D-phenylalanine attenuates brain acetylcholinesterase in neonatal streptozotocin-diabetic rats.Biochemical and Behavioral Evaluation of Human MAPT Mutations in Transgenic Drosophila melanogaster.Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
P2860
Q24631255-67D85D57-C299-4872-A383-74D3376570A1Q26749292-01E4213A-FF19-4EA5-8DEF-2F8D2C6CEFB3Q27691820-FCF725CB-C5E6-4603-B0CB-2A768085F9A7Q28078621-196FE96A-5981-4742-A80C-D17B9D211EA6Q28552100-77AF8A52-17C9-4778-A126-0FEBEAB5FD0FQ31143998-00D09190-0607-4C08-AA3B-292D1A76E0D7Q36904846-7EAAF540-064C-45D8-AC7E-BE028ABEBAE7Q37150643-83B1A98F-50A1-45CF-8B71-CCB93D88445FQ37318152-2CFD78EF-89DA-4A71-9BE6-409778C5EA67Q37639158-2F580650-5092-43C7-B236-73F3C6DE08A8Q37680018-D8AA8FEE-39CB-411E-9031-C6D9DB123C34Q37700135-7EEC20E9-5931-4917-9BFD-9FA68EAB6807Q37896141-D8B2FE30-DB81-4ACE-918B-8C67528F9C1FQ37912939-BABFB9C3-ABA0-4BE8-A0E6-7B3B651A025BQ38015342-DDE8759E-017F-48DE-B34E-A6C53AADF83DQ38166972-A580380B-D3BE-4C2F-8EE6-15734BC960BAQ38186060-736029A7-182F-4E54-B177-266206FB8252Q38961546-DB3C63F6-583C-4278-869D-2CB16F8C4403Q41248157-65AE6088-79A7-40C6-AA24-606263481A66Q42964588-309037B5-9579-4A0A-A581-F179E46393CCQ45935228-69550C04-74B2-4618-95FA-74D7614BCA2CQ47113717-44550CE7-A5BC-4AAB-9FEB-335F6EDB8800Q47624462-99B9AE48-BC53-4101-8943-677A82517C38Q47878674-AB24A039-306E-40A3-8A4C-B1A37D96418BQ48053493-461BA912-C404-4EDB-8D09-41F372103A2AQ48255025-F7360922-12F8-4D5E-98C8-E5CCFA605C21Q48332775-1501406B-E6A4-45BA-B954-9F73B282FE47Q48438680-50F4EAE9-5010-4A69-9B3C-8B9A8E9CFE4BQ50694227-06F2D4A7-9130-405F-9C3C-C226F332C210Q51811099-2AA3CDE3-AC20-48DF-B66E-45A3F0212CE6
P2860
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@ast
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@en
type
label
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@ast
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@en
prefLabel
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@ast
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@en
P2093
P356
P1476
Brain acetylcholinesterase act ...... and early Alzheimer's disease.
@en
P2093
Järvenpää T
Kaasinen V
Roivainen A
P304
P356
10.1136/JNNP.74.1.113
P407
P577
2003-01-01T00:00:00Z